T/SDHCST 001-2018 Active Group standards

T/SDHCST 001-2018 CTCs immunoassay technique protocol

T/SDHCST 001-2018 CTCs immunoassay technique protocol

Publish Date: 2018-04-16 Implement Date: 2018-04-16 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/SDHCST 001-2018
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: Integrated agriculture and forestry
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2018-04-16
Implement Date: 2018-04-16

Scope

Main technical content: This standard takes the domestically developed CTCBIOPSY detection system and supporting diagnostic reagents, which have obtained CFDA medical device registration certification, as the core. It proposes a standardized clinical treatment solution guided by CTC detection for the hot issues in the surgical precision treatment of common malignant tumors of the digestive system (esophageal cancer, gastric cancer, rectal cancer, and primary liver cancer) in China. This standard specifies the terms and definitions of CTC immunodetection technology, the principle of detection, technical indicators, relevant main instruments, diagnostic reagents, and requirements for preparation and detection methods. This standard is applicable to the rapid detection of abnormal cells in peripheral blood samples and blood samples collected from patients.

Development Information

Related Standards

Contact Us